P Markus Deckert
P Markus Deckert
Professor für Innere Medizin - Hämatologie/Onkologie, Medizinische Hochschule Brandenburg
Verified email at
Cited by
Cited by
Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer
J Atzpodien, H Kirchner, EL Hänninen, M Deckert, M Fenner, H Poliwoda
European Journal of Cancer 29, S6-S8, 1993
Current constructs and targets in clinical development for antibody-based cancer therapy
PM Deckert
Current drug targets 10 (2), 158-175, 2009
Targeted enzyme prodrug therapies
N Schellmann, PM Deckert, D Bachran, H Fuchs, C Bachran
Mini reviews in medicinal chemistry 10 (10), 887-904, 2010
A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy
PM Deckert, C Renner, LS Cohen, A Jungbluth, G Ritter, JR Bertino, ...
British journal of cancer 88 (6), 937-939, 2003
European studies of interleukin-2 in metastatic renal cell carcinoma.
J Atzpodien, H Kirchner, EL Hänninen, A Körfer, M Fenner, T Menzel, ...
Seminars in oncology 20 (6 Suppl 9), 22-26, 1993
Pharmacokinetics and microdistribution of polyethylene glycol‐modified humanized A33 antibody targeting colon cancer xenografts
PM Deckert, A Jungbluth, N Montalto, MA Clark, RD Finn, C Williams Jr, ...
International journal of cancer 87 (3), 382-390, 2000
Design, construction, and in vitro analysis of A33scFv:: CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer
V Coelho, J Dernedde, U Petrausch, H Panjideh, H Fuchs, C Menzel, ...
International journal of oncology 31 (4), 951-957, 2007
Expansion of Peripheral Blood Natural Killer Cells Correlates with Clinical Outcome in Cancer Patients Receiving Recombinant Subcutaneous lnterleukin-2 and Interferon-α-2
J Atzpodien, H Kirchner, A Körfer, M Hadam, A Schomburg, T Menzel, ...
Tumor biology 14 (6), 354-359, 1993
Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patients
S Duensing, I Dallmann, J Grosse, J Buer, E Lopez Hänninen, M Deckert, ...
Oncology 51 (4), 309-313, 1994
Diagnostic performance of contrast enhanced pulmonary computed tomography angiography for the detection of angioinvasive pulmonary aspergillosis in immunocompromised patients
C Henzler, T Henzler, D Buchheidt, JW Nance, CA Weis, R Vogelmann, ...
Scientific reports 7 (1), 4483, 2017
Ifosfamide/liposomal daunorubicin is a well tolerated and active first‐line chemotherapy regimen in advanced soft tissue sarcoma: Results of a Phase II study
JM Siehl, E Thiel, A Schmittel, G Hütter, PM Deckert, H Szelényi, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2005
Specific tumour localisation of a huA33 antibody-carboxypeptidase A conjugate and activation of methotrexate-phenylalanine
PM Deckert, WG Bornmann, G Ritter, C Williams, J Franke, U Keilholz, ...
International journal of oncology 24 (5), 1289-1295, 2004
A33scFv–Green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting
U Petrausch, J Dernedde, V Coelho, H Panjideh, D Frey, H Fuchs, E Thiel, ...
Protein Engineering, Design & Selection 20 (12), 583-590, 2007
Biodistribution and efficacy of [131I] A33scFv:: CDy, a recombinant antibody-enzyme protein for colon cancer
H Panjideh, VC Da Silva Coelho, J Dernedde, C Bachran, GJ Förster, ...
International journal of oncology 32 (4), 925-930, 2008
CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
PM Deckert, M Ballmaier, S Lang, H Deicher, I Schedel
Journal of immunology (Baltimore, Md.: 1950) 156 (2), 826-833, 1996
Production of bifunctional single-chain antibody-based fusion proteins in Pichia pastoris supernatants
H Panjideh, V Coelho, J Dernedde, H Fuchs, U Keilholz, E Thiel, ...
Bioprocess and biosystems engineering 31, 559-568, 2008
Molecular biomarkers of DNA damage in diffuse large-cell lymphoma—a review
M Ruhe, D Rabe, C Jurischka, J Schröder, P Schierack, PM Deckert, ...
J Lab Precis Med 4, 5, 2019
In vivo time and dose dependency of interleukin-6 secretion in response to low-dose subcutaneous recombinant interleukin-2
M Meffert, EL Hanninen, T Menzel, A Schomburg, S Duensing, I Dallmann, ...
Cancer Biotherapy & Radiopharmaceuticals 9 (4), 307-316, 1994
Treatment of Metastatic Colorectal Cancer Patients with 5-Fluorouracil in Combination with Recombinant Subcutaneous Human lnterleukin-2 and Alpha-lnterferon
J Atzpodien, H Kirchner, EL Hänninen, T Menzel, M Deckert, A Franzke, ...
Oncology 51 (3), 273-275, 1994
Quantification of DNA double-strand breaks in peripheral blood mononuclear cells from healthy donors exposed to bendamustine by an automated γH2AX assay—an exploratory study
S Rödiger, M Liefold, M Ruhe, M Reinwald, E Beck, PM Deckert
J Lab Precis Med 3, 47, 2018
The system can't perform the operation now. Try again later.
Articles 1–20